Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3739869014 | Product containing only emicizumab in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3739870010 | Emicizumab only product in parenteral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4633001000052117 | läkemedel som endast innehåller emicizumab, parenteral läkemedelsform | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing only emicizumab in parenteral dose form (medicinal product form) | Has manufactured dose form | Parenteral dose form (dose form) | true | Inferred relationship | Some | ||
| Product containing only emicizumab in parenteral dose form (medicinal product form) | Is a | Emicizumab-containing product in parenteral dose form | true | Inferred relationship | Some | ||
| Product containing only emicizumab in parenteral dose form (medicinal product form) | räkning av bas i aktiv ingrediens | ett | false | Inferred relationship | Some | ||
| Product containing only emicizumab in parenteral dose form (medicinal product form) | Is a | Emicizumab only product | true | Inferred relationship | Some | ||
| Product containing only emicizumab in parenteral dose form (medicinal product form) | Has active ingredient | Emicizumab | true | Inferred relationship | Some | 1 | |
| Product containing only emicizumab in parenteral dose form (medicinal product form) | Plays role | Hemostatic therapeutic role (role) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely emicizumab 30 milligram/1 milliliter conventional release solution for injection (clinical drug) | Is a | True | Product containing only emicizumab in parenteral dose form (medicinal product form) | Inferred relationship | Some | |
| Emicizumab 150 mg/mL solution for injection | Is a | True | Product containing only emicizumab in parenteral dose form (medicinal product form) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR